Innoviva, Inc.INVANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank64
3Y CAGR-9.6%
5Y CAGR+76.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-9.6%/yr
Annual compound
5Y CAGR
+76.5%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
17.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$30.60M+124.1%
2024$13.65M-59.7%
2023$33.92M-18.1%
2022$41.43M+7093.1%
2021$576000.00-67.8%
2020$1.79M-
2019$0.00-
2018$0.00-100.0%
2017$1.35M-2.7%
2016$1.39M-